Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Case Report - Journal of Cancer Immunology & Therapy (2022) Volume 5, Issue 6

Determination of oncolytic viruses based on cancer immunotherapy.

Various myelomas (MM) are a plasma cell harm that is described by insusceptible deregulation. MM is normally treated with immunomodulation specialists, yet stays serious. In this, we proposed and assessed immune stimulatory Lokon oncotic adenoviruses (Burden) for MM treatment. Load infections are serotype 5/35 fabrication, which empowers contamination of hematopoietic cells. Oncolysis is limited to cells with a deregulated retinoblastoma protein pathway, which is habitually seen in MM.

Author(s): Glen Harvey

Abstract Full Text PDF

Get the App